Company intelligence / Profile preview

Drug & Chemical Advisory Group

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Drug & Chemical Advisory Group (DCAG) is a strategic consulting firm providing specialized advisory services to the pharmaceutical, biotechnology, and fine chemical industries. The company focuses on business development, global sourcing of active pharmaceutical ingredients (APIs), and supply chain optimization. DCAG assists clients in navigating complex regulatory landscapes and identifying strategic growth opportunities through market intelligence and transaction support. Their expertise is frequently utilized for mergers, acquisitions, and the establishment of strategic partnerships within the global life sciences sector.

Industry: Consulting

Beyond the preview

Go deeper on Drug & Chemical Advisory Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drug & Chemical Advisory Group.

Explore the full profile